Study ID: LAQ-MS-305 | 2012-003647-30
Study Title
- The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
Teva Identifier
- LAQ-MS-305 | 2012-003647-30
ClinicalTrials.gov Identifier
- NCT01707992
Study Status
- Completed
Trial Condition(s)
- Multiple Sclerosis
Interventions
- Drug: Laquinimod | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 55 Years
Trial Duration
- February 20, 2013 - July 4, 2017
Phase
- Phase 3
Study Type
Interventional
